Table 1. The callus volume/bone volume ratio and BMD measured by microcomputed tomography at two and six weeks in the control, V5 (Vardenafil 5 mg) and V10 (Vardenafil 10 mg) groups.
2nd week | 6th week | p value | |
Mean±SE | Mean±SE | ||
Callus volume/bone volume (mm3/mm3) | |||
Control group | 1.41±0.22 | 0.69±0.05† | 0.0022 |
V5 group | 1.35±0.11 | 0.79±0.06*,† | 0.0022 |
V10 group | 1.42±0.15 | 0.80±0.04*,† | 0.0043 |
p value | 0.964 | 0.022 | |
BMD (g/cm3) | |||
Control group | 0.949±0.013 | 1.051±0.004† | 0.0022 |
V5 group | 0.974±0.009 | 1.051±0.008† | 0.0022 |
V10 group | 0.957±0.013 | 1.058±0.006† | 0.0022 |
p value | 0.373 | 0.665 | |
BMD: Bone mineral density; SE: Standard error; * p<0.05 vs control group; † p<0.01 vs 2nd week group. |